Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder-Reference-Cited by-同舟云学术

Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder

Published:2003-06 Issue:4 Volume:27 Page:619-623
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

D'Amico Giuseppina,Cedro Clemente,Muscatello Maria Rosaria,Pandolfo Gianluca,Di Rosa Antonio Enrico,Zoccali Rocco,La Torre Diletta,D'Arrigo Concetta,Spina Edoardo

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference37 articles.

1. Diagnostic and Statistical Manual of Mental Disorders,1994

2. Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study;Atmaca;Int. Clin. Psychopharmacol.,2002

3. Emergence of obsessive-compulsive symptoms during treatment with clozapine;Baker;J. Clin. Psychiatry,1992

4. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial;Bogetto;Psychiatry Res.,2000

5. Olanzapine: pharmacokinetic and pharmacodynamic profile;Callaghan;Clin. Pharmacokinet.,1999

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder;Psychiatric Quarterly;2021-04-08

2. Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders;Drugs in R&D;2018-08-31

3. Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder;Clinical Neuropharmacology;2016-01

4. Olanzapine;Meyler's Side Effects of Drugs;2016

5. Kombinationen mit Psychopharmaka in der Behandlung von Angst- und Zwangsstörungen;Polypharmazie in der Behandlung psychischer Erkrankungen;2015-11-25